These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 15835633)

  • 1. Clinical problem-solving. A sweet source of abdominal pain.
    Rogal SS; Ukomadu C; Levy BD; Loscalzo J
    N Engl J Med; 2011 May; 364(18):1762-7. PubMed ID: 21542747
    [No Abstract]   [Full Text] [Related]  

  • 2. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical resolution of glycogenic hepatopathy following improved glycemic control.
    Hudacko RM; Manoukian AV; Schneider SH; Fyfe B
    J Diabetes Complications; 2008; 22(5):329-30. PubMed ID: 18413180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it possible to predict the success of an intensified program of insulin therapy?].
    Bott U; Berger M
    Journ Annu Diabetol Hotel Dieu; 1998; ():289-313. PubMed ID: 9773628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Ceelie N
    Ned Tijdschr Geneeskd; 2005 Apr; 149(14):784. PubMed ID: 15835633
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
    Cusi K
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic steatohepatitis: natural history and diagnosis].
    Larrey D
    Gastroenterol Clin Biol; 2003; 27(8-9):793-8. PubMed ID: 14586250
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease of obesity.
    Sachdev MS; Riely CA; Madan AK
    Obes Surg; 2006 Nov; 16(11):1412-9. PubMed ID: 17132404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.